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Influenza A virus buds through the apical plasma membrane, forming enveloped virus particles that can take
the shape of pleomorphic spheres or vastly elongated filaments. For either type of virion, the factors respon-
sible for separation of viral and cell membranes are not known. We find that cellular Rab11 (a small
GTP-binding protein involved in endocytic recycling) and Rab11-family interacting protein 3 ([FIP3] which
plays a role in membrane trafficking and regulation of actin dynamics) are both required to support the
formation of filamentous virions, while Rab11 is additionally involved in the final budding step of spherical
particles. Cells transfected with Rab11 GTP-cycling mutants or depleted of Rab11 or FIP3 content by small
interfering RNA treatment lost the ability to form virus filaments. Depletion of Rab11 resulted in up to a
100-fold decrease in titer of spherical virus released from cells. Scanning electron microscopy of Rab11-
depleted cells showed high densities of virus particles apparently stalled in the process of budding. Trans-
mission electron microscopy of thin sections confirmed that Rab11 depletion resulted in significant numbers
of abnormally formed virus particles that had failed to pinch off from the plasma membrane. Based on these
findings, we see a clear role for a Rab11-mediated pathway in influenza virus morphogenesis and budding.
Influenza A virus is a highly infectious respiratory pathogen,
causing 3 to 5 million severe cases yearly while the recent
H1N1 pandemic has spread to over 200 countries and resulted
in over 15,000 WHO-confirmed deaths since its emergence in
March 2009 (57). Influenza virus particles are enveloped struc-
tures that contain nine identified viral polypeptides. The lipid
envelope is derived by budding from the apical plasma mem-
brane and contains the viral integral membrane proteins hem-
agglutinin (HA) and neuraminidase (NA) as well as the M2 ion
channel. Internally, virus particles contain a matrix protein
(M1), small quantities of the NS2/NEP polypeptide, and eight
genomic segments of negative-sense RNA that are separately
encapsidated into ribonucleoprotein (RNP) particles by the
viral nucleoprotein (NP) and tripartite polymerase complex
(PB1, PB2, and PA). M1 is thought to form a link between the
RNPs and the cytoplasmic tails of the viral membrane proteins
though M2 may also play a role (39). The minimal viral protein
requirements for budding are disputed; while initial studies
suggested that M1 was the main driver of budding (21, 34),
more recent work proposes that the glycoproteins HA and NA
are responsible (8).
Further complicating the analysis of influenza A virus bud-
ding is the observation that most strains of the virus form two
distinct types of virions: spherical particles approximately 100
nm in diameter and much longer filamentous particles up to 30
m in length (38). Of the viral proteins, M1 is the primary
determinant of particle shape (3, 17) although other virus
genes also play a role. It is also likely that host factors are
involved in the process as cells with fully differentiated apical
and basolateral membranes produce more filaments than non-
polarized cell types (42). While it is tempting to speculate that
virus morphology and budding are regulated by the same cel-
lular process, the fact that spherical budding occurs in the
absence of an intact actin cytoskeleton while filament forma-
tion does not (42, 48) indicates some level of divergence in the
mechanisms responsible for spherical and filamentous virion
morphogenesis.
The means by which viral and cellular membranes are sep-
arated are also unclear. Unlike many other enveloped viruses,
including retroviruses (19, 36, 52) and herpes simplex virus
(12), influenza A virus does not utilize the cellular endosomal
sorting complex required for transport (ESCRT) pathway (5,
8). However, recent reports indicate that some viruses, includ-
ing human cytomegalovirus (HCMV) (32), the hantavirus
Andes virus (44), and respiratory syncytial virus (RSV) may
employ a Rab11-mediated pathway during assembly and/or
budding (4, 51). The Rab family of small GTPases is involved
in targeting vesicle trafficking, mediating a wide range of down-
stream processes including endosomal trafficking and mem-
brane fusion/fission events (reviewed in references 53 and 58).
Rab11 is involved in trafficking proteins and vesicles between
the trans-Golgi network (TGN), recycling endosome, and the
plasma membrane (9, 49, 50) as well as playing a role in actin
remodeling, cytokinesis, and abscission (27, 41, 55). Apical
recycling endosome (ARE) trafficking is of particular interest
in the context of viral infection as other negative-sense RNA
viruses have been shown to assemble and/or traffic virion com-
ponents through the ARE prior to final assembly and budding
at the plasma membrane (4, 44, 51). Rab11 function is modu-
lated and targeted through interactions with Rab11 family
interacting proteins (Rab11-FIPs) that direct it to specific
subcellular locations (23, 25, 26) by binding to actin or micro-
tubule-based motor proteins (24, 26, 47). While Rab11-FIPs
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recognize both isoforms of Rab11 (a and b [Rab11a/b])
through a conserved amphipathic -helical motif, they differ in
their ability to bind either the GTP-bound form of Rab11
(FIP1, FIP3, FIP4, and Rip11) or both the GTP and GDP-
bound forms (FIP2) (23, 30). FIP1 and FIP2 have been impli-
cated in RSV budding (4, 51) while FIP4 is important for
trafficking of HCMV components (32). FIP3 has not previously
been linked with virus budding but plays an important role in
both cell motility and cytokinesis, regulating actin dynamics
and endosomal membrane trafficking (29, 55).
In light of the normal cellular functions of Rab11 and its
effectors and of their reported involvement in the budding of
other viruses, we examined the role of this cellular pathway in
influenza virus budding. We find that Rab11-FIP3 is essential
for filamentous but not spherical virion formation while Rab11
is required for both forms of virus budding.
MATERIALS AND METHODS
Cells, viruses, and plasmids. Human embryonic kidney 293T cells, CaCo2
colon carcinoma cells, and Madin-Darby canine kidney (MDCK) cells were
cultured as previously described (6). Cells were transfected with plasmids using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions
and incubated overnight before further analysis. For transfection of small inter-
fering RNAs (siRNAs), 293T cells were transfected approximately 18 h after
seeding using DharmaFECT transfection reagent (1 l/well; Dharmacon) to a
final siRNA concentration of 0.1 M and allowed to incubate for 72 h before
further analysis or infection.
An MDCK-adapted version of A/PR/8/34 virus (PR8) rescued from plasmids
(14) and grown in MDCK cells was used. A filamentous variant of PR8 virus
containing segment 7 from A/Udorn/72 (PR8 MUd) has been previously de-
scribed (40). A/Udorn/72 (Udorn) was the gift of Richard Compans (42, 48).
Herpes simplex virus (HSV) strain SC16 was used as previously described (5).
For influenza virus infections, virus was adsorbed to cells for 1 h in serum-free
medium at 37°C and overlaid in serum-free medium supplemented with 1 g/ml
trypsin and 0.14% bovine serum albumin (BSA) (for viral growth assays) or
medium containing serum (for microscopy). Titers of influenza viruses were
determined by plaque assay in MDCK cells (28, 37). Plasmids encoding green
fluorescent protein (GFP)-tagged dominant negative (DN) Rab11a (with the
mutation S25N) and constitutively active (CA) Rab11a (Q70L) (13), wild-type
(WT) Rab4, CA Rab4 (Q67L), and DN Rab4 (N121I) (46) proteins were gen-
erously supplied by Stephen Ferguson while WT Rab8, CA Rab8 (Q67L), and
DN Rab8 (T22N) (45) were provided by Folma Buss.
Protein analysis, immunofluorescence, antisera, and microscopy. For Western
blotting, samples were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes ac-
cording to standard procedures. Blots were developed using secondary antibod-
ies conjugated to IR Dye 680 or 800 and imaged and quantified on a LiCor
Biosciences Odyssey near-infrared imaging platform.
For fluorescence microscopy, cells were fixed with 4% formaldehyde and
processed for immunohistochemistry as previously described (18, 48). Rabbit
polyclonal antiserum to whole PR8 virus has been described previously (1).
Rabbit polyclonal antiserum to Rab11-FIP3 used in Western blotting was a gift
from Rytis Prekeris (55). Other reagents used in immunofluorescence were as
follows: rabbit polyclonal Rab11 (71-5300; Invitrogen), mouse monoclonal NP
(AA5H; Abcam ab20343), rabbit polyclonal NP (2915) (40), and Alexa Fluor
568-conjugated wheat germ agglutinin (WGA) (W11262; Invitrogen). Other
antibodies used in Western blotting were as follows; mouse monoclonal Rab11a
(47; Abcam ab78337), mouse polyclonal Rab11b (H00009230-B02F; Abnova),
and rat monoclonal -tubulin (YL1/2; MCA77G; AbD-Serotec). Rabbit poly-
clonal antisera to PR8 PB1 (V19), M1 (A2917), and whole PR8 virus have been
previously described (1, 15, 40).
Samples were imaged using a Leica TCS SP confocal microscope. Postcapture
processing of images to allow daylight visualization and reproduction was applied
equally to each experiment using Adobe Photoshop.
For scanning electron microscopy (SEM), cells were washed in 0.1 M HEPES
(pH 7.4)–2 mM CaCl2 and fixed overnight in the same buffer containing 0.3%
H2O2 and 4% electron microscopy (EM)-grade glutaraldehyde. Samples were
further processed by the Cambridge University Multi-Imaging Centre, Depart-
ment of Anatomy. For transmission electron microscopy (TEM), monolayers of
cells grown in 6-cm dishes were washed in 0.1 M HEPES, pH 6.4. The monolayer
was then covered in HEPES-glutaraldehyde-H2O2 and left at 4°C for 2 h. The
monolayer was washed with HEPES buffer, and cells were scraped into buffer
and harvested by centrifugation at 14,000  g for 10 min. The supernatant was
replaced with fresh HEPES buffer and sent to Cambridge University Multi-
Imaging Centre for further fixation and screening.
RESULTS
Role of Rab11 in influenza virus budding. To explore the
possibility that influenza virus buds via a Rab11-associated
mechanism, we first tested whether mutant Rab proteins with
alterations to their GTP-binding sites that resulted in either a
permanently GTP-bound, constitutively active (CA) protein or
a permanently GDP-bound, dominant negative (DN) protein
affected viral filament formation. CaCo2 cells were transfected
with plasmids that expressed various members of the Rab
family fused to GFP (or GFP only) and then infected with a
reassortant influenza virus (PR8 MUd) that produces large
numbers of filamentous virions (40). Cells were fixed at 16 h
postinfection (p.i.), stained for surface HA protein, and im-
aged in z-plane slices by confocal microscopy. Only back-
ground levels of antibody reactivity were observed in unin-
fected cells while the apical plasma membrane of infected but
untransfected cells stained strongly for HA, some of which
could be seen in characteristic micrometer-length protrusions
away from the plasma membrane (Fig. 1a, arrowheads), indi-
cative of bundles of viral filaments (40, 42, 48). Similar fila-
mentous structures were also seen protruding from cells trans-
fected with WT, CA, or DN forms of Rab4 or Rab8 or with
GFP only (Fig. 1a and data not shown). However, no filaments
were visible on the surface of cells expressing either the CA or
DN forms of Rab11 even though abundant cell surface HA was
still visible (Fig. 1a, top panels). When GFP-positive cells were
examined and scored for the presence or absence of filamen-
tous projections, around 60% of cells transfected with GFP
alone were found to have at least one large bundle of filaments
(Fig. 1b), in line with previous observations (40, 42, 48). Cells
expressing the WT, CA, or DN forms of Rab4 or Rab8 formed
filaments at a similar frequency. In contrast, there was a com-
plete absence of large filamentous structures protruding from
the surface of over 400 individual transfected cells expressing
either Rab11 CA or Rab11 DN (Fig. 1b).
Given the greatly decreased filamentous budding we ob-
served in the presence of Rab11 mutants unable to exchange
GTP, we tested whether the endogenous Rab11 protein or two
of its effectors were required for the formation of filamentous
virions. 293T cells were transfected with siRNAs targeted
against Rab11a, Rab11b, Rab11-FIP2, or Rab11-FIP3 or, as a
control, with nontargeting siRNAs to deplete the endogenous
pools of the respective proteins. First, we validated the effec-
tiveness of our siRNA treatments by Western blotting of cell
lysates at 72 h posttransfection. Comparison of samples from
cells treated with specific siRNAs with those of cells treated
with nontargeting siRNAs or nontreated cells showed reduc-
tions in the amounts of Rab11a, Rab11b, and FIP3 (Fig. 2a,
compare lanes 2 and 4 with lanes 1, 3, and 5). Quantification of
protein levels from replicate blots by densitometry confirmed
substantial depletion of all the targeted proteins: on average
Rab11a was depleted to 21% of normal levels, Rab11b was
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depleted to 8%, and Rab11-FIP3 was depleted to 4% (Fig. 2b).
We were unable to acquire a sample of an antibody to FIP2,
but reverse transcription-PCR (RT-PCR) analysis indicated
knockdown of mRNA levels by around 80% (data not shown).
Next, to assess the effect of Rab depletion on virus filament
formation, the morphology of the plasma membrane in siRNA-
treated, PR8 MUd-infected cells was investigated by staining with
the lectin WGA while virus infection was detected by staining for
intracellular NP. Mock-infected cells displayed prominent WGA
staining of a perinuclear compartment as well as faint staining of
the lateral plasma membrane (Fig. 3d). In contrast, the apical
surfaces of cells treated with a nontargeting siRNA and infected
with PR8 MUd were decorated with numerous filamentous pro-
jections, often protruding 10 to 20 m from the cell while, as
expected, the cytoplasm stained strongly for NP (Fig. 3a). Treat-
ment of cells with siRNAs against Rab11-FIP2 did not reduce the
numbers of virus-induced filamentous structures (Fig. 3e). How-
ever, depletion of Rab 11a or of both Rab11a and Rab11b or of
Rab11-FIP3 resulted in the almost complete absence of large
membrane protrusions produced by infected cells (Fig. 3b, c,
and f).
Light microscopy readily images bundles of large filaments
but does not reveal shorter virions of 1-m length (42, 48).
Accordingly, using SEM we imaged the surface of cells doubly
treated with siRNAs against Rab11a and Rab11b, singly
treated with siRNA against FIP3, or treated with control
siRNAs. At low magnification, the surfaces of mock-infected
cells treated with control or specific siRNA sequences ap-
peared similar, containing a number of microvilli or filopodia-
like structures as well as more lamellar protrusions (Fig. 4a, d,
and g), consistent with previous observations (20, 33). Low-
magnification imaging of the surfaces of PR8 MUd-infected
cells treated with control siRNA sequences showed similar
features but with the addition of striking 10- to 20-m length
spikes (Fig. 4b, arrows). At higher magnification, these were
seen to consist of bundles of multiple filamentous virions in
parallel array (Fig. 4c). Other patches of the plasma membrane
were profusely decorated with individual filamentous virus par-
ticles around 0.5 m in length, distinguishable from normal
cellular structures by their numbers and consistent diameter of
just under 100 nm (Fig. 4c arrowheads; see also Fig. 9a for
similar magnification images of uninfected cells). The surfaces
of PR8 MUd-infected cells depleted of Rab11 appeared much
smoother than those of the control siRNA-treated cells
(whether infected or uninfected), lacking obvious long bundles
of filamentous particles (Fig. 4e). At higher magnification, it
was evident that short filamentous virions as well as cellular
filopodia were also absent from the surfaces of infected Rab11
siRNA-treated cells (Fig. 4f). However, patches of protruding
100-nm-diameter spherical structures, reminiscent of spherical
influenza virus particles, were visible on the plasma membrane
(Fig. 4f). When infected, FIP3-depleted cells were examined,
prominent bundles of long viral filaments were also absent
although numerous short protrusions were still visible (Fig. 4
h). At high magnification, these were seen to consist of short
1m-length structures and an occasional longer filament
(Fig. 4i). The greater numbers of such structures on infected
cells (compare Fig. 4g, h, and i) make it likely that some are
viral in nature, but the imaging technique does not unambig-
uously identify the origin of individual protrusions. Neverthe-
less, it was clear that FIP3 depletion blocked the formation of
large numbers of long viral filaments, consistent with the
immunofluorescence analysis. SEM analysis confirmed that
siRNA targeting of FIP2 did not reduce filament formation
(data not shown). Overall, we therefore conclude that Rab11
and Rab11-FIP3 are essential for formation of filamentous
influenza virions. In contrast to results obtained with respira-
tory syncytial virus, however (51), Rab11-FIP2 is apparently
nonessential.
Filamentous strains of influenza A virus also produce spher-
ical particles (43), and loss of filamentous morphology on ad-
aptation to growth in eggs is often associated with higher titers
resulting from increased production of spherical particles (31).
It was therefore of interest to examine whether the loss of FIP3
blocked the production of spherical as well as filamentous
particles from PR8 MUd-infected cells. To this end, we exam-
FIG. 1. Effect of overexpressing GFP-tagged Rab polypeptides on
influenza virus filament formation. CaCo2 cells were transfected (or
mock transfected) with plasmids expressing the indicated GFP-tagged
polypeptides and incubated overnight before infection at a multiplicity
of infection of 10 with PR8 MUd. Cells were fixed at 16 h p.i., and cell
surface HA (stained in red by anti-PR8 serum) and GFP (green) were
imaged by confocal microscopy. (a) Representative z-plane reconstruc-
tions are shown. Scale bar, 5 m. (b) A minimum of 200 cells from two
independent experiments were scored for the presence or absence of
filamentous projections. The mean and range are plotted.
5850 BRUCE ET AL. J. VIROL.
ined infected cells by TEM. Uninfected cells treated with a
control siRNA exhibited relatively smooth plasma membranes,
with the occasional filopodium visible in cross section (Fig. 5a).
Control siRNA-treated, PR8 MUd-infected cells exhibited the
expected mixture of spherical (Fig. 5b, arrowheads) and fila-
mentous particles, which were most commonly seen in cross
section through the bundles (Fig. 5b, arrows). When infected,
FIP3-depleted cells were examined, released spherical parti-
cles were still visible (Fig. 5c, arrowheads), but consistent with
the previous experiments, no large bundles of filaments were
seen. However, the titer of infectious virus released from FIP3-
depleted cells was slightly lower (on average, 80%) than that
from control cells, suggesting that in this situation, loss of
filaments was not associated with increased production of
spherical particles. A similar outcome was seen when the ex-
periment was repeated with the filamentous Udorn strain of
FIG. 2. Cellular and viral protein accumulation in siRNA-treated cells. 293T cells were transfected (or mock transfected) with siRNA
sequences targeting the indicated cellular polypeptides. At 72 h post transfection the cells were infected (or mock infected where indicated) with
PR8 virus at a multiplicity of infection of 5 for 24 h before further analysis. (a and c) Cells were lysed and analyzed by Western blotting for the
indicated proteins. (b) Levels of the indicated proteins were quantified by densitometry, normalized to tubulin levels, and plotted as percentages
of the average amount contained in cells treated with nontargeting control or no RNA. The means and standard deviations (Rab11a, n  16; Rab
11b and FIP3, n  4; NP, n  4) are plotted. Note that the gel conditions used in the upper blot of panel c did not resolve PB1 and PB1-N40 (an
N-terminally truncated variant of PB1) (56).
FIG. 3. Influenza virus filament formation in siRNA-treated cells. 293T cells were transfected with siRNA sequences targeting the indicated
proteins or with a nontargeting control (a and d). At 72 h posttransfection cells were infected (or mock infected) with PR8 MUd at a multiplicity
of infection of 5, fixed at 16 h p.i., and stained with fluorescently tagged WGA to visualize the cell surface (red) as well as with anti-NP serum to
validate infection (green). Images are maximum intensity projections of confocal z-stacks taken through the cell at approximately 0.5-m steps.
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virus, with FIP3 depletion blocking the formation of long fila-
mentous bundles (data not shown) but decreasing overall titer
by only around one-third. Thus, FIP3 depletion specifically
blocks filamentous budding without having a major effect on
spherical virus budding.
Next, we further examined the role of Rab11 and associated
proteins in the production of spherical virus. To this end, 293T
and A549 cells were treated with siRNAs as above and infected
with a strain of influenza virus (PR8) that does not produce
filamentous particles (17). The titers of released virus were
FIG. 4. SEM analysis of filament formation in Rab11- or FIP3-depleted () cells. 293T cells were transfected with siRNA sequences targeting
Rab11a and Rab11b (d to f), FIP3 (g to i), or a nontargeting control (a to c), and infected with PR8 MUd at a multiplicity of infection of 5 at 72 h
posttransfection. At 16 h p.i. cells were fixed and processed for SEM imaging.
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then established by plaque assay. PR8 virus replicated equally
well in cells treated with nontargeting siRNA pools and in cells
that received no siRNA, producing titers greater than 107
PFU/ml in both cell types (Fig. 6a and b; values set as 100%).
Depletion of either Rab11-FIP2 or Rab11-FIP3 had no signif-
icant effect on virus titers, regardless of cell type. Reduction of
Rab11b levels in 293T cells also had little effect on virus rep-
lication but caused a more substantial 7-fold inhibition of virus
production in A549 cells. Similarly, reduction of Rab11a levels
caused a 2-fold decrease in titer of virus released from 293T
cells but had a much more pronounced effect in A549 cells,
where a greater than 10-fold decrease was seen. More striking,
however, was the drop in titer of virus released from cells
depleted of both Rab11a and Rab11b simultaneously, which
was on average 8-fold in 293T and 30-fold in A549 cells (Fig.
6a and b). While Rab11a/b-depleted A549 cells showed con-
sistent drops in virus titer to between 1% and 5% of the titer
in control cells, the output from depleted 293T cells was more
variable, ranging (in six independent experiments) from 33%
to 1%. The reason for this difference in behavior between the
two cell types is not clear but may reflect variations in siRNA
transfection efficiency. To examine the specificity of the re-
quirement for Rab11 in influenza A virus replication, we tested
the effect of depleting cells of Rab11a and Rab11b on repli-
FIG. 5. TEM analysis of viral budding in FIP3-depleted cells. 293T cells were transfected with nontargeting siRNA sequences (a and b) or
siRNA against FIP3 (c) and infected or mock infected as labeled with PR8 MUd at a multiplicity of infection of 5 at 72 h posttransfection. At 16 h
p.i. cells were fixed and processed for TEM imaging. Scale bar, 500 nm. Arrowheads indicate spherical virus particles; arrows indicate cross sections
through bundles of filaments.
FIG. 6. Virus replication in siRNA-treated cells. 293T or A549 cells were transfected (or mock transfected) with siRNA sequences targeting
the indicated cellular polypeptides. At 72 h posttransfection the cells were infected with PR8 virus (influenza A virus [IAV]) at a multiplicity of
infection of 5 or with HSV at a multiplicity of infection of 10. Supernatants from infected cells were harvested at 24 h p.i., and titers were
determined by plaque assay. The titers obtained from nontransfected cells and cells treated with nontargeting siRNAs were averaged and defined
as 100%. The mean and standard error (IAV-infected 293T cells, n 4 replicate experiments; IAV-infected A549 cells, n 3; HSV-infected 293T
cells, n  2) are plotted.
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cation of HSV, a virus whose budding is known to involve the
cellular ESCRT pathway (5, 12). In contrast to the results
obtained with influenza virus, HSV replicated to similar titers
in control and Rab11a/b-depleted cells (Fig. 6c).
As a further control, we assessed viral protein production in
Rab11a/b-depleted cells to control for the possibility that re-
duced levels of virus replication might result from lower infec-
tion rates of the depleted cells or reduced virus gene expres-
sion. However, the levels of NP, M1, HA, and PB1
accumulation showed no significant variation between non-
transfected cells or cells treated with control or Rab11 siRNAs
(Fig. 2c). When NP accumulation was quantified from repli-
cate experiments, no significant change was seen to result from
Rab11/b depletion (Fig. 2b). Thus, Rab11 plays a role down-
stream of viral gene expression in the formation of both spher-
ical and filamentous influenza virus particles while FIP3 is
specifically required for filamentous budding.
Colocalization of Rab11 and influenza virion components.
Since Rab11 is involved in directing vesicular traffic to and
from the recycling endosome and the plasma membrane (49),
it could potentially play roles in trafficking viral components to
the site of budding, as well as (or in addition to) the final
membrane scission step. We therefore explored the localiza-
tion of Rab11 in relation to the viral nucleoprotein. 293T cells
were either infected with PR8 or mock infected, and the lo-
calizations of endogenous Rab11 and influenza NP were visu-
alized at 6 h p.i. by immunofluorescence. In mock-infected
cells, speckles of Rab11 were found throughout the cytoplasm
along with a predominant perinuclear focus (Fig. 7a), in agree-
ment with a prior study showing its localization to the recycling
endosome and TGN as well as on cytoplasmic cargo vesicles
(9). In infected cells, NP localized to cytoplasmic puncta that,
as expected (6), tended to concentrate at the plasma mem-
brane although some NP accumulation was observed at a
perinuclear structure (Fig. 7a). Virus infection was not associ-
ated with any obvious change in Rab11 localization at 6 h p.i.
However, a striking degree of colocalization between Rab11
and NP was seen, both for the perinuclear structure and for the
cytoplasmic puncta (Fig. 7a). Next, we tested for colocalization
of NP and the GFP-tagged Rab11 CA and DN mutants as
previous work reports distinct localization patterns for the two
activity states. The CA (GTP-bound) form of Rab11 localizes
to the recycling endosome and more-peripheral vesicular
structures, while DN (GDP-bound) Rab11 is primarily associ-
ated with the TGN (9, 44). 293T cells were transfected with the
GFP-tagged Rab11 constructs, infected with PR8, and stained
at 6 h p.i. for NP before visualization by confocal microscopy.
CA GFP-Rab11 localized to dispersed cytoplasmic structures
(Fig. 7b), often with a perinuclear accumulation in the lower
midbody of the cells (data not shown), consistent with previous
reports (9, 44). Moreover, these punctate accumulations of CA
Rab11 showed a high degree of colocalization with NP, espe-
cially toward the apical cell surface (Fig. 7b). In contrast, the
majority of the GDP-bound DN Rab11 fusion protein local-
ized to a perinuclear compartment likely to be the TGN (9, 44)
based on its colocalization with the marker TGN46 (data not
shown), and although some diffuse cytoplasmic staining was
visible, this did not colocalize significantly with NP (Fig. 7c).
Given the extensive colocalization between Rab11 and NP,
it was possible that the reduction in virus replication seen after
FIG. 7. Colocalization of Rab11 and influenza virus NP. (a) 293T cells were mock infected or infected as labeled with PR8 at a multiplicity of
infection of 5, fixed at 6 h p.i., and stained for Rab11 (green), NP (red), and DNA (blue). (b and c) Cells were transfected with plasmids encoding
GFP-tagged CA or DN Rab11 proteins, infected 18 h posttransfection, and stained at 6 h p.i. for NP and DNA. Single optical slices are shown.
Scale bar, 4 m.
5854 BRUCE ET AL. J. VIROL.
siRNA depletion of Rab11 resulted from disruption of normal
RNP trafficking. To test this, we examined NP localization
in siRNA-treated 293T cells. In cells treated with control
siRNAs, NP exhibited the expected distribution of a mixture of
nuclear and cytoplasmic staining at 6 h p.i., followed by con-
centration at the plasma membrane late in infection (Fig. 8a,
upper panels). No major changes to this pattern were seen in
cells depleted of Rab11a and Rab11b (Fig. 8a, lower panels).
Similar results were obtained when infection was carried out
with the filamentous PR8 MUd virus (data not shown). Rab11
function has previously been found nonessential for surface
transport of HA (9, 11), consistent with the normal levels of
surface HA we saw in the presence of mutant forms of Rab 11
(Fig. 1a). Nevertheless, to test whether this was also the case
after siRNA treatment, we examined surface HA staining in
PR8 MUd-infected cells depleted of Rab11a/b or FIP3. Abun-
dant staining was seen in all infected cells, whether treated
with specific or control siRNAs though, as expected, large
bundles of viral filaments were seen only in the control cells
(Fig. 8b).
Next, we therefore investigated whether the drop in virus
titer after Rab11 depletion was the result of a defect in bud-
ding. SEM was used to examine the surface topography of
mock- or PR8-infected cells treated with nontargeting control
or Rab11a/b siRNA sequences at 16 h postinfection. As before,
depletion of Rab11 did not noticeably alter the appearance of
mock-infected cells; both control and Rab11 siRNA-treated
cells formed filopodia and microvilli but largely lacked 100-
nm-diameter spherical structures that could be mistaken for
virus particles (Fig. 9a and b). Such spherical structures of the
correct size to be influenza virions were, however, observed on
the surface of PR8-infected cells treated with a nontargeting
siRNA control, as expected (Fig. 9c). The density of budding
varied from cell to cell, from sparse to profuse, but a typical
cell harbored a few hundred well-spaced virions (Fig. 9c). Sim-
ilar size protrusions were also seen on the surface of infected,
Rab11-depleted cells (Fig. 9d), but the overall density of virus
particles was higher, with many Rab11-depleted cells showing
excessive retention of what appeared to be fully formed virus
particles on the plasma membrane, to the point that, in certain
regions, there were so many virions in close proximity that they
formed a pavement-like array (Fig. 9d, inset).
To examine the morphology of these virus-like structures in
more detail, the budding of individual virions from Rab11-
depleted cells was examined using thin-section TEM. The
plasma membrane of mock-infected cells treated with control
siRNA appeared relatively smooth though filopodia were ob-
served in cross section (Fig. 10e). In PR8-infected cells treated
with the nontargeting siRNA control, abundant spherical in-
fluenza virions were visible (Fig. 10a and c). Consistent with
previous observations (10), the majority of virus particles had
apparently either completely separated from the plasma mem-
brane and presented a circular cross section (Fig. 10a) or were
attached by thin “necks” and retained an elongated morphol-
ogy (Fig. 10c, white arrowheads). However, in cells depleted of
Rab11 we observed a large number of virions whose appear-
ance suggested slowed or abnormal budding events (Fig. 10b,
d, and f). In some cases, budding virions appeared to consist of
doubled, perhaps “daisy-chained,” particles budding from a
single site (Fig. 10b, asterisks). These structures resembled
late-stage budding-defective HIV particles formed in cells
overexpressing dominant negative components of the ESCRT
pathway (35, 52). In many other cases, the budding virions
remained attached to the cell by thick stalks of membrane, in
clear contrast to the narrow structures normally seen tethering
immature virions to the cell surface (Fig. 10b, arrowheads, and
d; compare with panel c). In apparently more extreme cases,
what appeared to be budding virus particles protruded from
FIG. 8. NP and HA localization in Rab11- or FIP3-depleted cells. 293T cells were transfected with siRNA sequences targeting Rab11a and
Rab11b, FIP3, or a nontargeting control as indicated and infected (or mock infected) with PR8 at a multiplicity of infection of 5 at 72 h post
transfection. (a) At 6 and 20 h p.i. cells were fixed and permeabilized before staining for NP. Single optical slices are shown. Each panel represents
a 150- by 135-m window. (b) At 16 h p.i. cells were fixed and stained for HA. Maximum intensity projections of a set of optical sections through
the upper halves of the cells are shown. Scale bar, 10 m.
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broad platforms of the plasma membrane (Fig. 10f). Taking
these data in conjunction with the decrease in virus titer and
the number of virions seen by SEM to be retained on the cell
surface of Rab11 siRNA-treated cells, it appears that the de-
pletion of Rab11 results in a late-stage defect in virus budding.
DISCUSSION
All enveloped viruses face the problem of separating viral
and cellular membranes to release a fully formed virion. In
some cases, this energetically unfavorable process is thought to
be primarily overcome by “pulling” forces generated by inter-
actions between the viral capsid and membrane proteins (54).
Another (not mutually exclusive) paradigm holds that mem-
brane scission is driven by an external “push” from coopted
cellular proteins, most notably the ESCRT machinery (7). In
the case of influenza virus, the lack of a rigid internal capsid
and the extreme variation in particle lengths produced by fila-
mentous strains perhaps argue against sole use of a pulling mech-
anism. Equally, however, evidence argues strongly against use of
the best-characterized cellular system for providing a push (5, 8).
We provide evidence here that influenza virus utilizes the Rab11
pathway for budding, a cellular system whose normal role, like
that of the ESCRT machinery, is in directing vesicular traffic.
We base our conclusions on the findings that GTP-cycling
mutants of Rab11 (but not other Rab proteins) interfere with
filamentous budding (Fig. 1), that siRNA depletion of Rab11
reduces the titer of released virus (Fig. 6), and, most impor-
tantly, that EM imaging of virus budding in Rab11-depleted
cells shows structures consistent with defective budding (Fig. 4,
9, and 10). Similar occurrences of what are clearly virus parti-
cles that have yet to start the pinching-off process have been
observed previously in normal infected cells, where they were
interpreted as representing intermediate steps in the budding
process (10). We also saw these types of budding events in
normal (as well as control siRNA-treated) cells, but in agree-
ment with previous work (10), they were rare occurrences, with
the majority of particles being either completely detached or
attached by a narrow stalk (Fig. 10 and data not shown).
Accordingly, it is the much larger numbers of such apparent
“intermediate” structures in Rab11-depleted cells that lead us
to define the outcome as defective budding. We did not ob-
serve complete cessation of viral release in Rab11-depleted
cells as assessed by viral titer, and while this may reflect only a
partial reduction in Rab11 expression, it would be interesting
to know whether the incomplete budding events we observed
represent truly stalled episodes of particle formation or just
slower assembly kinetics.
Our data can be interpreted in light of a pulling model,
where virus budding is driven largely by forces generated by
self-assembly of viral proteins within the nascent particle, or of
a pushing model, where cellular functions are redirected to the
viral bud. The pulling model would predict that virus budding
is reduced because of insufficient delivery of crucial viral struc-
tural proteins to the bud zone. The pushing model predicts that
the absence of Rab11 leads to a failure to recruit the cellular
machinery responsible for membrane scission. Both models
are compatible with the normal cellular functions of Rab11
FIG. 9. SEM visualization of virus budding in Rab11-depleted cells. 293T cells were transfected with siRNA sequences targeting Rab11a and
Rab11b (b and d) or a nontargeting control (a and c), and either mock infected or infected with PR8 at a multiplicity of infection of 5 at 72 h
posttransfection. At 16 h p.i. cells were washed and fixed overnight on coverslips before processing for SEM. Scale bar, 2 m.
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and its interaction partners in regulating vesicular traffic to and
from the plasma membrane, TGN, and recycling endosome as
well as in cytokinesis (22, 58).
The pulling model is consistent with the extensive colocal-
ization we observe between Rab11 and NP (Fig. 7) as the
coincidence of the two polypeptides suggests a mechanism for
transporting RNPs across the cytoplasm to the apical plasma
membrane, which accordingly could be perturbed by disrup-
tion of Rab11 function. However, we saw no major change in
NP localization in the presence of Rab11 mutants or in Rab11-
depleted cells (Fig. 7 and 8). This apparently normal localiza-
tion of NP after Rab11 depletion is perhaps surprising, but one
possible explanation for this is that Rab11 levels were not
reduced sufficiently to cause a trafficking defect. We also saw
normal levels of surface HA in the presence of Rab11 mutants
(Fig. 1) or after siRNA treatment (Fig. 8), consistent with
previous studies that found Rab11 function nonessential for
surface transport of HA (9, 11). Thus, while we would not rule
out a role for the Rab11 pathway in trafficking of virion com-
ponents to the plasma membrane, we do not think that this is
the primary cause of the budding defect.
Instead, we currently favor the hypothesis that Rab11 plays
a role in influenza virus budding by recruiting the cellular
machinery necessary for assisting in the separation of viral and
FIG. 10. TEM visualization of budding virions in Rab11-depleted cells. 293T cells were transfected with siRNA sequences targeting Rab11a
(b), Rab11a and Rab11b (d and f), or a nontargeting control (a, c, and e), and mock infected (e) or infected with PR8 at a multiplicity of infection
of 5 at 72 h posttransfection. At 16 h p.i. cells were fixed and processed for TEM. Scale bar, 100 nm.
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cellular membranes. This is consistent with the high densities
of virus particles visible on the surface of Rab11-depleted cells
by SEM (Fig. 9) and the common occurrence of finding bud-
ding particles in cross section that often appeared reasonably
normal except for the width of the neck between virion content
and cytoplasm (Fig. 10b and d). The identity of the actual
protein(s) responsible for pinching off the membrane in this
model is unknown; although Rab proteins are accepted to have
functions in both membrane fusion and membrane scission,
the former process is much better characterized (22, 58). Nev-
ertheless, the yeast homologues of Rab11, Ypt31 and Ypt32,
have been shown to be involved in exocytic traffic from the
Golgi stack, probably at the point of membrane scission (2).
Although not topologically equivalent to virus budding, the
function is nevertheless suggestive. Further work is required to
determine whether Rab11 plays a direct role in separating viral
and cellular membranes or an indirect one via the recruitment
of other cellular factors.
The identity of the Rab11 FIP(s) used during influenza virus
budding is also uncertain. Unlike the case with RSV (51), we
saw no role for FIP2, either in supporting spherical particle
release or in filamentous virion formation. While we saw a
strong dependence on FIP3 for production of influenza virus
filaments (Fig. 3 to 5), this was not mirrored by any require-
ment for spherical virus budding, as assessed by the titer of
replicated virus (Fig. 6). This does, however, indicate that
filament and spherical virus budding are biochemically sepa-
rable events, consistent with their differential dependence on
the actin cytoskeleton (42, 48). Indeed, FIP3 also interacts with
the actin-regulating protein Arf6 at the plasma membrane (16,
25), so it is possible that the differential requirements for FIP3
and the actin cytoskeleton during viral morphogenesis are part
of the same process.
We have previously considered the hypothesis that filamen-
tous influenza virions are produced when a budding particle
fails to engage the cellular machinery necessary for membrane
scission (5). Evidence in support of such a mechanism exists for
RSV, where expression of a DN FIP2 polypeptide inhibited the
release of infectious virus but actually made filaments longer
(51). However, for influenza virus, loss of FIP3 or Rab11 abol-
ished the filamentous phenotype (Fig. 3 to 5 and 9) rather than
making viral budding hyperfilamentous. Similarly, loss of FIP3
or Rab11 did not convert PR8 budding into a filamentous
phenotype, but, instead, Rab11 depletion led to slow or stalled
production of spherical particles (Fig. 9 and 10). As discussed
above, this could reflect profound differences in the cellular
pathways used for filamentous and spherical budding by influ-
enza virus rather than that the two forms of virion represent
different ends of the same spectrum. An alternative possibility
is that filament formation and spherical particle formation are
mechanistically linked but that forming a filament requires
more than one Rab11-dependent step. Work is ongoing to test
between these possibilities.
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